Table 3 The reversed differential abundant metabolites.

From: Characterization of the effects of oxymatrine on myocardial hypertrophy in spontaneously hypertensive rats through transcriptomics and metabolomics

Name

SHR vs. WKY

Regulate

SHR + OM vs. SHR

Regulate

log2FC

P value

log2FC

P value

Desoxycortone

4.65732

1.87E−04

Up

− 2.07728

0.010358

Down

NP-011548

1.78125

0.025835

Up

− 1.84752

0.025955

Down

Indoleacetic acid

1.66280

9.91E-04

Up

− 0.68767

0.047282

Down

Pivaloylcarnitine

1.40275

0.003446

Up

− 1.01760

0.016360

Down

14-hydroxy-12-tetradecenoic acid

1.18886

0.013925

Up

− 1.32010

0.008301

Down

(R)-3-Hydroxy myristic acid

0.99838

0.019578

Up

− 1.35239

0.010091

Down

NP-003692

0.99790

0.044030

Up

− 1.39320

0.012629

Down

(1S,2S)-3-oxo-2-pentyl-cyclopentanehexanoic acid

0.93464

0.037393

Up

− 1.18098

0.014096

Down

2alpha-(3-Hydroxypropyl)-1alpha,25-dihydroxy-19-norvitamin D3

0.92181

0.006314

Up

− 0.71314

0.026404

Down

16-Hydroxyhexadecanoic acid

0.86631

0.038897

Up

− 1.03519

0.025712

Down

7-Ethyl-3,5-dimethyl-2E,4E,6E,8E-decatetraene

0.84283

0.036625

Up

− 0.98439

0.018504

Down

Heptadecanoyl carnitine

0.79108

0.028904

Up

− 1.13377

0.008778

Down

PC(18:2(9Z,12Z)/19:0)

0.76807

0.016721

Up

− 0.42592

0.031530

Down

NP-021797

0.65196

0.032161

Up

− 0.78957

0.019832

Down

Ricinoleic acid

0.46809

0.01593

Up

− 0.515600

0.012908

Down

1-O-(2R-methoxy-4Z-tetradecenyl)-sn-glycerol

0.46809

0.01593

Up

− 0.515600

0.012908

Down

Decanoylcarnitine

− 1.15309

0.009779

Down

− 1.78046

0.015920

Down